Management of recurrent or persistent choroidal neovascularization secondary to age-related macular degeneration A prospective, randomized, clinical study

To assess the treatment effect of reduced fluence photodynamic therapy (PDT) and ranibizumab versus intravitreal dexamethasone and ranibizumab versus ranibizumab monotherapy in patients with persistent or recurrent CNV due to AMD.